Replies to post #306967 on Elite Pharmaceuticals Inc (ELTP)

[namtae]

My sentiments exactly

Thanks for setting the record straight. I haven't had time as im interviewing new MSL candidates

[WeeZuhl]

In medicine, we know that it is quite rare that only one theory of disease intervention is correct.

Yes, and in medicine we also know receptor affinity is an objective measure, and we know isradipine is at the top of the list for relative affinity to CaV1.3 compared with CaV1.2. We also know isradipine is the only CCB chosen for Phase 2 and Phase 3 studies, which are now completed. If STEADY-PDIII has good results, isradipine scripts will skyrocket, and no amount of nonsense made-up "FUD" will affect it.